Media Summary: FDA experts demonstrate the FDA's Generic Drug User Fee Amendments (GDUFA) Science and Research Program's ... This presentation described content and format requirements for composition This presentation explained factors that could impact first-cycle bioequivalence (BE) adequacy based on observed BE ...
Agdd 2024 D1s16 Closing Remarks - Detailed Analysis & Overview
FDA experts demonstrate the FDA's Generic Drug User Fee Amendments (GDUFA) Science and Research Program's ... This presentation described content and format requirements for composition This presentation explained factors that could impact first-cycle bioequivalence (BE) adequacy based on observed BE ... Lei Zhang, PhD, Deputy Director for the Office of Regulatory Science, delivers This presentation recognized the significant challenges associated with conducting comparative clinical endpoint (CCEP) ... Robert Lionberger, PhD, Director for the Office of Regulatory Science, delivers
This public workshop communicated how FDA's Generic Drug User Fee Amendments (GDUFA) Science and Research Program ...
